HDL cholesterol efflux normalised to apoA-I is associated with future development of type 2 diabetes: from the CORDIOPREV trial

by Ruth Blanco-Rojo, Pablo Perez-Martinez, Javier Lopez-Moreno, Javier Martinez-Botas, Javier Delgado-Lista, Ben van-Ommen, Elena Yubero-Serrano, Antonio Camargo, Jose M. Ordovas, Francisco Perez-Jimenez, Diego Gomez-Coronado, Jose Lopez-Miranda
Published 2017

Evolution of Metabolic Phenotypes of Obesity in Coronary Patients after 5 Years of Dietary Intervention: From the CORDIOPREV Study

by Laura Martin-Piedra, Juan F. Alcala-Diaz, Francisco M. Gutierrez-Mariscal, Antonio P. Arenas de Larriva, Juan L. Romero-Cabrera, Jose D. Torres-Peña, Javier Caballero-Villarraso, Raul M. Luque, Pablo Perez-Martinez, Jose Lopez-Miranda, Javier Delgado-Lista
Published 2021

Hypertriglyceridemia influences the degree of postprandial lipemic response in patients with metabolic syndrome and coronary artery disease: from the CORDIOPREV study.

by Juan F Alcala-Diaz, Javier Delgado-Lista, Pablo Perez-Martinez, Antonio Garcia-Rios, Carmen Marin, Gracia M Quintana-Navarro, Purificacion Gomez-Luna, Antonio Camargo, Yolanda Almaden, Javier Caballero, Francisco J Tinahones, Jose M Ordovas, Francisco Perez-Jimenez, Francisco Perez-Jimenez, Jose Lopez-Miranda
Published 2014